MedTrace Logo

Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias

NCT02290600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2018-07-12

No results posted yet for this study

Summary

The purpose of this 12 week feasibility study is to see how much more accurate a continuous glucose monitor (CGM) might be in individuals with type 1 diabetes if the investigators personalize sensor calibrations to the user, based on previous wear.

Conditions

Interventions

DEVICE

Continuous Glucose Monitor

CGM sensor calibration individualization

Sponsors & Collaborators

  • Sansum Diabetes Research Institute

    lead OTHER

Principal Investigators

  • Jordan Pinsker, M.D. · Sansum Diabetes Research Institute

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-10-31
Completion
2016-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02290600 on ClinicalTrials.gov